Complete financial analysis of THC Farmaceuticals, Inc. (CBDG) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of THC Farmaceuticals, Inc., a leading company in the Biotechnology industry within the Healthcare sector.
- Concord Acquisition Corp III (CNDB) Income Statement Analysis – Financial Results
- T.M.C. Industrial Public Company Limited (TMC.BK) Income Statement Analysis – Financial Results
- Landore Resources Limited (LND.L) Income Statement Analysis – Financial Results
- Diales Plc (DIAL.L) Income Statement Analysis – Financial Results
- Cisco Systems, Inc. (4333.HK) Income Statement Analysis – Financial Results
THC Farmaceuticals, Inc. (CBDG)
About THC Farmaceuticals, Inc.
THC Farmaceuticals, Inc. owns and operates non-financial institution cash-dispensing automated teller machines at third-party owned retail and commercial locations. The company's machines are placed in hotels, stores, bowling alleys, and other high customer traffic areas for small and medium sized businesses. As of June 30, 2015, it had a total of eight machines for public use along the Wasatch Front in the State of Utah. The company was formerly known as City Media, Inc. and changed its name to THC Farmaceuticals, Inc. in February 2015. THC Farmaceuticals, Inc. was founded in 2008 and is based in Scottsdale, Arizona. THC Farmaceuticals, Inc. operates as a subsidiary of Weed Growth Fund, Inc.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 10.00K | 2.23K | 7.58K | 10.19K | 12.21K | 12.95K | 17.07K | 19.03 | 21.64 |
| Cost of Revenue | 4.95K | 3.81K | 952.00 | 0.00 | 2.63K | 0.00 | 0.00 | 0.00 | 12.30 | 16.80 |
| Gross Profit | -4.95K | 6.19K | 1.28K | 7.58K | 7.56K | 12.21K | 12.95K | 17.07K | 6.73 | 4.84 |
| Gross Profit Ratio | 0.00% | 61.92% | 57.39% | 100.00% | 74.16% | 100.00% | 100.00% | 100.00% | 35.38% | 22.37% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 30.15 | 23.38 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | -25.00K | 14.68K | 19.09K | 39.32K | 165.65K | 26.50K | 19.64K | 152.59K | 30.15 | 23.38 |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | -25.00K | 14.68K | 19.09K | 39.32K | 165.65K | 26.50K | 19.64K | 152.59K | 30.75 | 24.43 |
| Cost & Expenses | 29.95K | 18.49K | 20.04K | 40.27K | 168.29K | 27.45K | 20.25K | 153.19K | 43.05 | 41.23 |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 6.68 | 4.25 |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 6.68K | 4.25K |
| Depreciation & Amortization | 4.95K | 3.81K | 952.00 | 952.00 | 953.00 | 953.00 | 605.00 | 605.00 | 0.60 | 1.05 |
| EBITDA | -25.00K | 429.87K | -15.85K | -119.70K | -994.19K | -14.29K | -6.70K | -135.51K | -23.42K | -18.54K |
| EBITDA Ratio | 0.00% | 4,298.69% | -754.70% | -419.14% | -1,541.65% | -117.05% | -51.74% | -793.77% | -123.03% | -85.66% |
| Operating Income | -29.95K | -8.49K | -17.81K | -32.70K | -158.09K | -15.24K | -7.30K | -136.12K | -24.02 | -19.59 |
| Operating Income Ratio | 0.00% | -84.91% | -797.22% | -431.68% | -1,550.97% | -124.84% | -56.38% | -797.28% | -126.18% | -90.50% |
| Total Other Income/Expenses | 0.00 | 434.55K | 1.00K | -87.95K | -837.05K | -5.00 | 0.00 | 0.00 | -6.68K | -4.25K |
| Income Before Tax | -29.95K | 426.06K | -16.81K | -120.65K | -995.14K | -15.25K | -7.30K | -136.12K | -30.70 | -23.84 |
| Income Before Tax Ratio | 0.00% | 4,260.61% | -752.28% | -1,592.73% | -9,762.99% | -124.88% | -56.38% | -797.26% | -161.27% | -110.15% |
| Income Tax Expense | -14.98K | 433.71K | -8.39K | -60.21K | -496.58K | -3.00 | -5.00 | -5.00 | 0.00 | 0.00 |
| Net Income | -14.98K | 426.91K | -8.42K | -60.45K | -498.57K | -15.25K | -7.30K | -136.12K | -30.70 | -23.84 |
| Net Income Ratio | 0.00% | 4,269.05% | -376.90% | -797.95% | -4,891.26% | -124.88% | -56.38% | -797.26% | -161.27% | -110.15% |
| EPS | 0.00 | 0.02 | 0.00 | 0.00 | -0.03 | 0.00 | 0.00 | -0.01 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.02 | 0.00 | 0.00 | -0.03 | 0.00 | 0.00 | -0.01 | 0.00 | 0.00 |
| Weighted Avg Shares Out | 18.13M | 18.13M | 18.13M | 16.63M | 16.63M | 15.25M | 15.13M | 15.13M | 8.97K | 8.97K |
| Weighted Avg Shares Out (Dil) | 18.13M | 18.13M | 18.13M | 16.63M | 16.63M | 15.25M | 15.13M | 15.13M | 8.97K | 8.97K |
Source: https://incomestatements.info
Category: Stock Reports